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Abstract
Objective
Developmental delay is one of the most common causes of conferring the pediatric 
neurologist. The main part of neurological growth and development occur in the 
first two years especially in the first 6 months of life. Metabolic or skeletal diseases 
are important causes of developmental delay. Early diagnosis of deviance from the 
normal diagram of development in lower ages is important.
Materials & Methods
Specific ages and stages questionnaires (ASQ) for 6 months was completed in the 
health centers for 800 infants conferring for their vaccination in Isfahan and the retest 
was performed at 24 months of age by ASQ and then these two questionnaires were 
compared.
Results
10.5% of the infants were delayed in at least one domain. At 24 months, 38.4% 
of them remained delayed; 21.1% in one domain, 9.6% in two domains, 3.8% 
in four domains and 3.8% in five domains. Of the children who had problem in 
communication, 20%; in gross motor, 25%; in fine motor, 20%; and in problem 
solving, 30% remained delayed. In the personal social domain, none of the delayed 
children at 6 months remained delayed at 24 months.
Conclusion
ASQ is feasible, inexpensive, easy to use and was appreciated by the parents. It can 
be used as a screening test for detection of developmental delay in lower ages, but its 
results must be followed by other standard tests or diagnostic tools.
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Introduction
Developmental delay is one of the most common causes of referring children to 
pediatric neurological clinics. In several studies which were performed in different 
countries, the prevalence of these disorders has been estimated as 10% (1,2).
Developmental delay includes two major groups: cerebral palsy and progressive 
brain disorders or neurodegenerative disorders. These diseases globally constitute 
developmental disorder in the child. Early diagnosis of patients with developmental 
delay especially cerebral palsy is important in four aspects:
1- Due to neuroplasticity, primary treatment is effective in the future prognosis.
2- Early interference prevents the severity of the disorder (2) and early diagnosis 
may prevent the incidence of skeletal deformity and contracture, behavioural 
disorder and other outcomes of brain disorders.
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3-Earlier diagnosis of diseases leads to earlier 
corresponding of parents with rehabilitative team 
members and sooner use of rehabilitator guidance 
and other treatments.
4- Finally, side effects such as contracture and deformity 
do not appear in infancy; therefore, treatment will be 
accomplished in shorter time leading to lower costs 
for the family and therapeutic centers.
In addition to all of the named problems, the importance 
of earlier neurological exams in infants is clear. Because 
by early diagnosis of infants who are not on the normal 
developmental pathway, they will be treated earlier and 
it will be possible to prevent metabolic disorders to 
become more severe and on the other hand, the ASQ test 
approved and translated by the ministry of health and 
medical education of Iran will be used as a screening 
tool for Iranian children and we can use this test in upper 
levels for all newborns because ASQ is an inexpensive 
and sensitive method (2) and it may be used as a parent-
completed screening test.
Some of the symptoms of developmental delay are 
not diagnosable by mothers and the family and even 
physicians. So it is possible to perform screening tests 
earlier than 6 months for detection of cases who are 
apparently normal. In our study, for better evaluation of 
the children, we used instructed questioners. Besides, our 
effort was to find these developmental disorders earlier 
and in lower ages. According to the above-mentioned 
conditions the best age this study is assessable is 
considered as 6 months. This study was a survey of the 
prevalence of developmental delay in infants who confer 
for their sixth month vaccination in Isfahan city.
Materials & Methods
This is a descriptive study that was carried out from 
May 2010 to May 2012 in health centers in Isfahan. The 
under study group were infants coming for their 6 month 
vaccination to health centers. 
Scale of entrance
Infants who came to health centers for their 6-month 
vaccination.
Scale of exclusion
Incomplete personal data in the questionnaire such as 
phone number and infants who did not confer with the 
paediatric neurologist for follow up.
Method of sampling and sample volume
Based on the 10% prevalence of this disorder (p=10%) 
and a 95% confidence factor (z=1.96) and a 0.02accuracy 
rate (d=0.02),with this formula 
 
the acquired 
sample volume was 865 cases.ASQ test was done for all 
the cases.
ASQ questionnaire includes five sub tests: 
communication, coarse motor activity, fine motor 
activity, language and social domains.
Data selection
ASQ is a questionnaire that can screen the developmental 
status of the children from 4 to 60 months in five different 
domains: communication, gross motor, fine motor, 
problem solving and personal social skills. Each domain 
is evaluated by six questions regarding what the child 
can or cannot do. They are selected as representatives 
of a developmental quotient of75-100%. The parents’ 
answer to each question is “yes” to indicate that the 
child does the specific behavior of this item (score, 
10 points), ‘‘sometimes’’ to indicate an occasional or 
emerging response (score, 5 points) and ‘‘not yet’’ to 
indicate that their was no response (score, 0).Then, the 
scores of each item are summed and the final score in 
each domain is compared with cut-off points of the ASQ 
guidelines. The score on any domain below the cut-off 
point is considered abnormal and is referred for further 
evaluation (8 - 12).
Our questioners in health centers completed ASQ 
questionnaires for the infants who came for their 
6-month vaccination and because almost always infants 
in this age confer for their vaccination, results of this 
study generate good prospect about the prevalence of 
these disorders among infants in this age group.
In this study, questions about 6 months and then questions 
about second age 24 months were asked. Then with 
the Z static test the prevalence of developmental delay 
globally and separately in each domainregarding gender 
were obtained. Infants who did not achieve a complete 
score in the ASQ test were evaluated again at 24 months 
with the ASQ test and some of them who did not get 
a complete score again, were followed. Some of them 
were house rested by a pediatric neurologist and others 
were recommended to confer a pediatric neurologist.
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Ethics
We informed the parents that this is a research plan and 
we discussed the methodology. This study was ethically 
confirmed by the ethics committee of Isfahan University 
of Medical Sciences.
Results
In the present study, 800 six-month-old children (432 
boys, 369 girls) were screened using the ASQ test. 10.5% 
of them (84 children) consisting 40 girls (10.8% of total 
girls) and 44 boys (10.2% of total boys) had scores lower 
than the cut off point in at least one of ASQ test domains. 
They were followed by ASQ test again at 24 months. 
At 6 months, of these 84 children, 19.2% had problem 
in the communication domain, 30.7% in gross motor, 
53.8% in fine motor, 26.9% in problem solving and 
7.6% in personal social.
Of the 84 cases, 32had no phone number or their phone 
number had changed or their parents did  not respond. 
Therefore, 32 children were excluded from the study. 
Finally, 52 children (29 boys, 23 girls) were followed by 
the ASQ test at 24 months. Of these 52 children in the 
first screening test at 6 months, 69.2% had a problem in 
one domain, 23.2% in two domains and 7.6% in three 
domains.
In the retest at 24 months, 61.6% had no problem, 21.1% 
had problem in one domain, 9.6% in two domains, 3.8% 
in four domains and 3.8% in five domains. Actually of 
the 52 cases, 38.4% remained delayed in at least one 
domain.
According to Pearson’s correlation test there is direct 
relationship between the number of problems in the first 
test at 6 months and the number of problems in the retest 
at 24 months.
Using Mc Nemar test, 9.5% of the cases, which were 
normal in the communication domain at 6 months 
became delayed at 24 months and 20% of the delayed 
children at 6 months remained delayed at 24 months. 
5.5% of the cases that were normal in gross motor at 
6 months became delayed at 24 months and 25% of 
the delayed children at 6 months, remained delayed at 
24 months.12.6% of the cases that were normal in fine 
motor at 6 months became delayed at 24 months and 
20% of delayed children at 6months remained delayed 
at 24 months. 20% of the cases, who were normal in 
solving problem at 6 months, became delayed and 30% 
of delayed children at 6 months remained delayed at 24 
months. 12.5% of normal children in personal social 
domain at 6 months became delayed and from those 
who were delayed at 6 months none were delayed at 24 
months.
Discussion
Early detection and intervention of children with 
developmental delays or disorders is an important issue 
in pediatric medicine. Early detection and intervention 
in developmental problems can reduce their impact on 
the child’s well-being (12). 
In the present study, the prevalence of developmental 
delay among infants who confer for their 6 months 
vaccination was 10.5%, 10.8% in girls and 10.2% in 
boys, which was relatively consistent with the results of 
other studies performed in Iran. There were no relation 
between the prevalence of developmental delay and 
gender.
According to our study, children who had more problems 
in the first test had more problems in the retest. The 
problem of 70% of the children, who had one problem in 
the first test, was solved completely in the retest. In 50% 
of children with a problem in two domains in the first 
test, the problem was solved completely in the second 
test. Any of the children with a problem in three domains 
did not become problem-free in the retest.
A study in Tehran city showed that the prevalence of 
developmental delay among 4 to 60-month-old children 
was 18% using ASQ test (13), which was higher than 
our results. In other study in Tehran, the prevalence 
of developmental delay among 0 to 6-year-olds was 
evaluated as 12% using ASQ test and the evaluation by 
developmental pediatricians (14). 
In a study in Canada it was shown that the sensitivity 
and specificity of ASQ test among the community were 
100% and 90%, respectively (15).
In another study, the results of ASQ and BSID II (Bayley 
Scale of Infant development II) were compared and it 
was shown that their results in communication, personal 
social and gross motor domains were correlated, but 
there were no correlation between them in fine motor 
and problem solving (16). 
In a study on 4 to 60-month-old children in Tehran, the 
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prematurely within a population-based program over 30 
years. JAMA. 2007;297(24):2733-40. 
8. Lindsay NM, Healy GN, Colditz PB, Lingwood BE. Use 
of the Ages and Stages Questionnaire to predict outcome 
after hypoxic–ischemic encephalopathy in the neonate. J 
Pediatr Child Health. 2008; 44(10):590-5.
9. Yu LM, Hey E, Doyle LW, Farrell B, Spark P, Altman DG 
et al. Evaluation of the Ages and Stages Questionnaires 
in identifying children with neurosensory disability 
in the Magpie Trial follow-up study. Acta Paediatr. 
2007;96(12):1803-8.
10. Squires J, Bricker D, Potter L. Revision of a parent 
completed development screening tool: Ages and Stages 
Questionnaires. J Pediatr Psychol. 1997;22(3):313-28.
11. Glascoe FP. Screening for developmental and 
behavioral problems. Ment Retard Dev Disabil Res Rev. 
2005;11(3):173-9.
12. Richter J, Janson H. A validation study of the Norwegian 
version of the Ages and Stages Questionnaires. Acta 
Paediatr. 2007;96(5):748-52.
13. Shashani S, Vameghi R, Azari N, Sajedi F, Kazemnejad 
A. Comparing the results of developmental screening of 
4-60 months old children in Tehran using ASQ & PDQ. 
Iran Rehabil J. 2011;11(14):3-7.
14. Shashani S, Vameghi R, Azari N, Sajedi F, KazemnejadA. 
Validity and reliability determination of Denver 
developmental screening test- II in 0-6 years old in 
Tehran. Iran J Pediatr. 2010;20(3):313-22.
15. Jorina E, Andrew M, Elaine M, Faitb G. The Age and 
Stage Questionnaires: feasibility of use as a screening tool 
for children in Canada. Can Rural Med. 2008; 13(1):9-14.
16. Gollenberg AI, Lynch CD, Jackson LW, Guinness BM, 
Msall ME. Concurrent validity of the parent-completed 
Ages and Stages Questionnaires, 2nd Ed. with the Bayley 
Scales of Infant Development IIin a low risk sample. 
Child Care Health Dev, 2010;36(4):485-90.
results of ASQ and PDQ (Prescreening Developmental 
Questionnaire) were compared and it was shown that the 
results were different (13).
 In the present study, we found that ASQ is a feasible, 
easy to use and inexpensive test for developmental 
delay screening. Parents had good compliance even in 
the second test, whichwas done via telephone. We have 
to mention the fact that there were some problems with 
this method of screening, for example parents of child 
who had to be visited by a pediatric neurologist didnot 
go to the clinic. Additionally, ASQ is not diagnostic and 
its results must be followed by more evaluations such as 
being visited by pediatricians.
ASQ seems to be an appropriate screening test. 
In conclusion, ASQ is feasible, inexpensive, easy to 
use, and is appreciated by the parents (15).It can be used 
as a screening test for the detection of developmental 
delay in lower ages, but its results must be followed by 
other standard tests or diagnostic tools.
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